Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
10:05am, Wednesday, 23'rd Oct 2024
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Abbott Laboratories: Promising Growth, Yet Fully Valued; A Wait-And-Watch Stock
09:59am, Wednesday, 23'rd Oct 2024
Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive growth following a drop in Covid-test demand. The company reported 9% revenue
MDT vs. ABT: Which Stock Is the Better Value Option?
12:45pm, Monday, 21'st Oct 2024
Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or Abbott (ABT). But which of these two companies is the best option for those looking for u
What Drove Abbott's Q3?
08:00am, Monday, 21'st Oct 2024
Abbott (NYSE: ABT) recently reported its Q3 results, with revenues and earnings slightly above our expectations. The company reported revenue of $10.64 billion and earnings of $1.21 on a per-share and
Abbott Laboratories: Long-Term Optimism, Short-Term Overvaluation
06:26am, Monday, 21'st Oct 2024
Abbott Laboratories is a diversified healthcare company with strong segments, particularly Medical Devices, contributing to steady growth and consistent dividends. ABT's Q2 earnings showed solid perfo
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
09:57am, Saturday, 19'th Oct 2024
These companies' longtime shareholders have generally been rewarded.
3 Fortune 500 Industry Leaders Boast Ideal October Dividends
03:51am, Saturday, 19'th Oct 2024
The June/July 2024 edition of Fortune revealed the 500 biggest U.S. companies by revenue and profits. Dogcatcher's quest to sniff-out the best dividend-buys focused on 66 industry-leader profits per Y
Wall Street Analysts Think Abbott (ABT) Is a Good Investment: Is It?
10:35am, Friday, 18'th Oct 2024
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
05:10am, Friday, 18'th Oct 2024
These stocks could deliver big over the long term.
Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic
02:42pm, Thursday, 17'th Oct 2024
On Wednesday, Abbott Laboratories ABT reported third-quarter sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion.
Calls of the Day: Crowdstrike, Cheniere Energy, 3M, Abbott Labs, Abbvie and Eli Lilly
02:15pm, Thursday, 17'th Oct 2024
The Investment Committee debate the latest Calls Of The Day.
Abbott's Growth and Dividends Make It a Smart Portfolio Pick
12:57pm, Thursday, 17'th Oct 2024
There are many reasons to own Abbott Laboratories ABT, but they all boil down to one thing: consistent market-beating returns. A study published by Hendrik Bessembinder, a professor of finance at Ariz
These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings
09:14am, Thursday, 17'th Oct 2024
Abbott Laboratories ABT reported better-than-expected third-quarter results on Wednesday.
Abbott Laboratories: It's No Longer A Buy For Now
07:30am, Thursday, 17'th Oct 2024
Since my previous article, shares of Abbott Laboratories have returned 10% versus the 7% gains of the S&P 500 index. The healthcare company's sales and adjusted diluted EPS rose in the third quarter.
Wake Up, It's Time To Pick Stocks: Here Are 2 Dividend Stocks I Love
07:30am, Thursday, 17'th Oct 2024
This article emphasizes the importance of stock picking in today's market, where elevated valuations and sector rotations make it essential for generating returns. I've identified two dividend stocks
